Qian Tao - Publications

Affiliations: 
Clinical Oncology The Chinese University of Hong Kong, Hong Kong, Hong Kong 
Area:
Oncology, Genetics, Molecular Biology

190 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Chen M, Shan H, Tao Q, Hu R, Sun Q, Zheng M, Chen Z, Lin Q, Yin M, Zhao S, Chen X, Chen Z. Mimicking Tumor Metastasis Using a Transwell-Integrated Organoids-On-a-Chip Platform. Small (Weinheim An Der Bergstrasse, Germany). e2308525. PMID 38308351 DOI: 10.1002/smll.202308525  0.361
2023 Yue C, Qian Y, Wang C, Chen J, Wang J, Wang Z, Wan X, Cao S, Zhu J, Tao Q, Yan M, Liu Q. TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. Cancer Science. PMID 37248790 DOI: 10.1111/cas.15852  0.316
2023 Xie J, Zhou J, Xia J, Zeng Y, Huang G, Zeng W, Fan T, Li L, Zeng X, Tao Q. Phospholipase C delta 1 inhibits WNT/β-catenin and EGFR-FAK-ERK signaling and is disrupted by promoter CpG methylation in renal cell carcinoma. Clinical Epigenetics. 15: 30. PMID 36849889 DOI: 10.1186/s13148-023-01448-2  0.393
2023 Li L, Shu XS, Geng H, Ying J, Guo L, Luo J, Xiang T, Wu L, Ma BBY, Chan ATC, Zhu X, Ambinder RF, Tao Q. A novel tumor suppressor encoded by a 1p36.3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagy. Cell Death and Differentiation. PMID 36813924 DOI: 10.1038/s41418-023-01129-w  0.759
2023 Kuang Y, He Z, Li L, Wang C, Cheng X, Shi Q, Fu G, Ying J, Tao Q, Hu X. The developmental regulator HAND1 inhibits gastric carcinogenesis through enhancing ER stress apoptosis targeting CHOP and BAK which is augmented by cisplatin. International Journal of Biological Sciences. 19: 120-136. PMID 36594085 DOI: 10.7150/ijbs.76345  0.633
2022 Li S, He X, Wang Y, Chen W, Sun R, Tian S, He S, Pu C, Li C, Zhou D, Jiang Y, Tao Q, Li L, Ye L, Wu Y, et al. Zinc-finger protein 382 antagonises CDC25A and ZEB1 signaling pathway in breast cancer. Genes & Diseases. 10: 568-582. PMID 37223530 DOI: 10.1016/j.gendis.2021.12.019  0.311
2022 Ying Y, Wang M, Chen Y, Li M, Ma C, Zhang J, Huang X, Jia M, Zeng J, Wang Y, Li L, Wang X, Tao Q, Shu XS. Zinc finger protein 280C contributes to colorectal tumorigenesis by maintaining epigenetic repression at H3K27me3-marked loci. Proceedings of the National Academy of Sciences of the United States of America. 119: e2120633119. PMID 35605119 DOI: 10.1073/pnas.2120633119  0.601
2022 Li L, Xu J, Qiu G, Ying J, Du Z, Xiang T, Wong KY, Srivastava G, Zhu XF, Mok TS, Chan AT, Chan FK, Ambinder RF, Tao Q. Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum. Theranostics. 12: 1736-1737. PMID 35198069 DOI: 10.7150/thno.70351  0.605
2022 Ying K, Wang C, Liu S, Kuang Y, Tao Q, Hu X. Diverse Ras-related GTPase DIRAS2, downregulated by PSMD2 in a proteasome-mediated way, inhibits colorectal cancer proliferation by blocking NF-κB signaling. International Journal of Biological Sciences. 18: 1039-1050. PMID 35173535 DOI: 10.7150/ijbs.68312  0.305
2021 Tang J, Peng W, Feng Y, Le X, Wang K, Xiang Q, Li L, Wang Y, Xu C, Mu J, Xu K, Ji P, Tao Q, Huang A, Deng CX, et al. Cancer cells escape p53's tumor suppression through ablation of ZDHHC1-mediated p53 palmitoylation. Oncogene. PMID 34282274 DOI: 10.1038/s41388-021-01949-5  0.366
2020 Zhu J, Li L, Tong J, Hui C, Wong CH, Lo KW, Chan R, Ai QY, Hui EP, Chan AT, To KF, Tao Q, Ma BB. Targeting the polycomb repressive complex-2 related proteins with novel combinational strategies for nasopharyngeal carcinoma. American Journal of Cancer Research. 10: 3267-3284. PMID 33163269  0.4
2020 Le X, Mu J, Peng W, Tang J, Xiang Q, Tian S, Feng Y, He S, Qiu Z, Ren G, Huang A, Lin Y, Tao Q, Xiang T. DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis. Theranostics. 10: 9495-9511. PMID 32863941 DOI: 10.7150/Thno.45631  0.536
2020 He J, Wu M, Xiong L, Gong Y, Yu R, Peng W, Li L, Li L, Tian S, Wang Y, Tao Q, Xiang T. BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27. Clinical Epigenetics. 12: 82. PMID 32517789 DOI: 10.1186/S13148-020-00867-9  0.376
2020 Lee HM, Sia APE, Li L, Sathasivam HP, Chan MSA, Rajadurai P, Tsang CM, Tsao SW, Murray PG, Tao Q, Paterson IC, Yap LF. Monoamine oxidase A is down-regulated in EBV-associated nasopharyngeal carcinoma. Scientific Reports. 10: 6115. PMID 32273550 DOI: 10.1038/S41598-020-63150-0  0.43
2020 Sun R, Xiang T, Tang J, Peng W, Luo J, Li L, Qiu Z, Tan Y, Ye L, Zhang M, Ren G, Tao Q. 19q13 KRAB zinc-finger protein ZNF471 activates MAPK10/JNK3 signaling but is frequently silenced by promoter CpG methylation in esophageal cancer. Theranostics. 10: 2243-2259. PMID 32089740 DOI: 10.7150/thno.35861  0.517
2019 Xiang T, Tang J, Li L, Peng W, Du Z, Wang X, Li Q, Xu H, Xiong L, Xu C, Le X, Wei X, Yu F, Li S, Xiao Q, ... ... Tao Q, et al. Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis. Theranostics. 9: 8182-8195. PMID 31754389 DOI: 10.7150/Thno.34983  0.598
2019 Li L, Fan Y, Huang X, Luo J, Zhong L, Shu XS, Lu L, Xiang T, Chan ATC, Yeo W, Chen C, Chan WY, Huganir RL, Tao Q. Tumor Suppression of Ras GTPase-Activating Protein RASA5 through Antagonizing Ras Signaling Perturbation in Carcinomas. Iscience. 21: 1-18. PMID 31654850 DOI: 10.1016/J.Isci.2019.10.007  0.796
2019 Ying Y, Wang Y, Huang X, Sun Y, Zhang J, Li M, Zeng J, Wang M, Xiao W, Zhong L, Xu B, Li L, Tao Q, Wang X, Shu XS. Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1. Oncogene. PMID 31591481 DOI: 10.1038/S41388-019-1013-1  0.644
2019 Mohamed G, Talima S, Li L, Wei W, Rudzki Z, Allam RM, Simmons W, Tao Q, Murray PG. Low Expression and Promoter Hypermethylation of the Tumour Suppressor SLIT2, are Associated with Adverse Patient Outcomes in Diffuse Large B Cell Lymphoma. Pathology Oncology Research : Por. PMID 30739251 DOI: 10.1007/S12253-019-00600-9  0.435
2018 Zhang Y, Fan J, Fan Y, Li L, He X, Xiang Q, Mu J, Zhou D, Sun X, Yang Y, Ren G, Tao Q, Xiang T. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest. Clinical Epigenetics. 10: 26. PMID 30359298 DOI: 10.1186/S13148-018-0459-2  0.77
2018 Ye L, Xiang T, Fan Y, Zhang D, Li L, Zhang C, He X, Xiang Q, Tao Q, Ren G. The 19q13 KRAB Zinc-finger protein ZFP82 suppresses the growth and invasion of esophageal carcinoma cells through inhibiting NF-κB transcription and inducing apoptosis. Epigenomics. PMID 30211622 DOI: 10.2217/Epi-2018-0092  0.418
2018 Li L, Ma BBY, Chan ATC, Chan FKL, Murray P, Tao Q. Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas. Pathogens (Basel, Switzerland). 7. PMID 30022006 DOI: 10.3390/Pathogens7030063  0.549
2018 Wang L, Fan Y, Zhang L, Li L, Kuang G, Luo C, Li C, Xiang T, Tao Q, Zhang Q, Ying J. Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201701453RR. PMID 29957056 DOI: 10.1096/Fj.201701453Rr  0.707
2018 Liu X, Qiao B, Zhao T, Hu F, Lam AK, Tao Q. Sox2 promotes tumor aggressiveness and epithelial‑mesenchymal transition in tongue squamous cell carcinoma. International Journal of Molecular Medicine. PMID 29956740 DOI: 10.3892/ijmm.2018.3742  0.398
2018 Zhang C, Xiang T, Li S, Ye L, Feng Y, Pei L, Li L, Wang X, Sun R, Tao Q, Ren G. The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling. Cell Death & Disease. 9: 573. PMID 29760376 DOI: 10.1038/S41419-018-0604-Z  0.547
2018 Qi XK, Han HQ, Zhang HJ, Xu M, Li L, Chen L, Xiang T, Feng QS, Kang T, Qian CN, Cai MY, Tao Q, Zeng YX, Feng L. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma. Theranostics. 8: 2202-2216. PMID 29721073 DOI: 10.7150/Thno.24003  0.453
2018 Wen H, Ma H, Cai Q, Lin S, Lei X, He B, Wu S, Wang Z, Gao Y, Liu W, Liu W, Tao Q, Long Z, Yan M, Li D, et al. Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma. Nature Medicine. PMID 29291352 DOI: 10.1038/Nm.4456  0.396
2018 Li L, Xu J, Qiu G, Ying J, Du Z, Xiang T, Wong KY, Srivastava G, Zhu XF, Mok TS, Chan AT, Chan FK, Ambinder RF, Tao Q. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas. Theranostics. 8: 61-77. PMID 29290793 DOI: 10.7150/Thno.20893  0.715
2017 Shao B, Feng Y, Zhang H, Yu F, Li Q, Tan C, Xu H, Ying J, Li L, Yang D, Peng W, Tang J, Li S, Ren G, Tao Q, et al. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer. Journal of Cellular and Molecular Medicine. PMID 29193730 DOI: 10.1111/Jcmm.13404  0.676
2017 Li X, Wu XQ, Deng R, Li DD, Tang J, Chen WD, Chen JH, Ji J, Jiao L, Jiang S, Yang F, Feng GK, Senthilkumar R, Yue F, Zhang HL, ... ... Tao Q, et al. CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of Id and neuroblastoma cell differentiation. Nature Communications. 8: 1159. PMID 29079782 DOI: 10.1038/S41467-017-01272-2  0.374
2017 Shu XS, Zhao Y, Sun Y, Zhong L, Cheng Y, Zhang Y, Ning K, Tao Q, Wang Y, Ying Y. PBRM1 restricts the basal activity of innate immune system through repressing RIG-I-like receptor signaling and is a potential prognostic biomarker for colon cancer. The Journal of Pathology. PMID 28940253 DOI: 10.1002/Path.4986  0.619
2017 Hu X, Kuang Y, Li L, Tang H, Shi Q, Shu X, Zhang Y, Chan FK, Tao Q, He C. Epigenomic and Functional Characterization of Junctophilin 3 (JPH3) as a Novel Tumor Suppressor Being Frequently Inactivated by Promoter CpG Methylation in Digestive Cancers. Theranostics. 7: 2150-2163. PMID 28656064 DOI: 10.7150/Thno.18185  0.732
2017 Mu J, Hui T, Shao B, Li L, Du Z, Lu L, Ye L, Li S, Li Q, Xiao Q, Qiu Z, Zhang Y, Fan J, Ren G, Tao Q, et al. Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer. Oncotarget. PMID 28467796 DOI: 10.18632/oncotarget.17055  0.402
2017 Luo X, Xiong X, Shao Q, Xiang T, Li L, Yin X, Li X, Tao Q, Ren G. The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation. Oncotarget. PMID 28388578 DOI: 10.18632/Oncotarget.16511  0.548
2017 Liu X, Hu X, Kuang Y, Yan P, Li L, Li C, Tao Q, Cai X. BCLB, methylated in hepatocellular carcinoma, is a starvation stress sensor that induces apoptosis and autophagy through the AMPK-mTOR signaling cascade. Cancer Letters. PMID 28259820 DOI: 10.1016/J.Canlet.2017.02.030  0.486
2017 Li L, Li C, Mao H, Du Z, Chan WY, Murray P, Luo B, Tak-Cheung Chan A, Shu-Kam Mok T, Ka-Leung Chan F, Ambinder R, Tao Q. Epigenetic Inactivation of the CpG Demethylase TET1 as a DNA Methylation Feedback Loop in Upper Aerodigestive Tract and Gastrointestinal Cancers Clinical Gastroenterology and Hepatology. 15: e46. DOI: 10.1016/J.Cgh.2016.09.111  0.399
2016 Li L, Li C, Mao H, Du Z, Chan WY, Murray P, Luo B, Chan AT, Mok TS, Chan FK, Ambinder RF, Tao Q. Corrigendum: Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers. Scientific Reports. 6: 34435. PMID 27708339 DOI: 10.1038/Srep34435  0.349
2016 Xiang T, Fan Y, Li C, Li L, Ying Y, Mu J, Peng W, Feng Y, Oberst M, Kelly K, Ren G, Tao Q. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells. Oncotarget. PMID 27708215 DOI: 10.18632/Oncotarget.12341  0.761
2016 Yin X, Xiang T, Mu J, Mao H, Li L, Huang X, Li C, Feng Y, Luo X, Wei Y, Peng W, Ren G, Tao Q. Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer. Oncotarget. PMID 27351130 DOI: 10.18632/oncotarget.10102  0.473
2016 Li L, Li C, Mao H, Du Z, Chan WY, Murray P, Luo B, Chan AT, Mok TS, Chan FK, Ambinder RF, Tao Q. Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers. Scientific Reports. 6: 26591. PMID 27225590 DOI: 10.1038/Srep26591  0.621
2016 Du Z, Li L, Huang X, Jin J, Huang S, Zhang Q, Tao Q. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation. Oncotarget. PMID 26943038 DOI: 10.18632/Oncotarget.7822  0.606
2016 Zhao L, Li S, Gan L, Li C, Qiu Z, Feng Y, Li J, Li L, Li C, Peng W, Xu C, Wang Z, Hui T, Ren G, Tao Q, et al. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression. Journal of Cellular and Molecular Medicine. PMID 26843424 DOI: 10.1111/Jcmm.12768  0.488
2015 Zhao T, Hu F, Liu X, Tao Q. Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ERK signaling pathways. Oncotarget. PMID 26497550 DOI: 10.18632/oncotarget.5468  0.32
2015 Yu J, Li X, Tao Q, Yu XL, Cheng ZG, Han ZY, Guo M, Liang P. Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation. Gut. PMID 26289056 DOI: 10.1136/Gutjnl-2015-310258  0.478
2015 Li C, Tang L, Zhao L, Li L, Xiao Q, Luo X, Peng W, Ren G, Tao Q, Xiang T. OPCML is frequently methylated in human colorectal cancer and its restored expression reverses EMT via downregulation of smad signaling. American Journal of Cancer Research. 5: 1635-48. PMID 26175934  0.5
2015 Li X, Yu J, Brock MV, Tao Q, Herman JG, Liang P, Guo M. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU. Oncotarget. 6: 11547-60. PMID 25909168 DOI: 10.18632/Oncotarget.3413  0.481
2015 Zhao T, Hu F, Qiao B, Chen Z, Tao Q. Telomerase reverse transcriptase potentially promotes the progression of oral squamous cell carcinoma through induction of epithelial-mesenchymal transition. International Journal of Oncology. 46: 2205-15. PMID 25775973 DOI: 10.3892/ijo.2015.2927  0.393
2015 Zhang L, Zhang Q, Li L, Wang Z, Ying J, Fan Y, He Q, Lv T, Han W, Li J, Yang Y, Xu B, Wang L, Liu Q, Sun Y, ... ... Tao Q, et al. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer. Journal of Molecular Medicine (Berlin, Germany). 93: 691-701. PMID 25648635 DOI: 10.1007/S00109-015-1255-5  0.794
2015 Chen YW, Guo T, Shen L, Wong KY, Tao Q, Choi WW, Au-Yeung RK, Chan YP, Wong ML, Tang JC, Liu WP, Li GD, Shimizu N, Loong F, Tse E, et al. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma. Blood. 125: 1589-600. PMID 25612622 DOI: 10.1182/Blood-2014-07-588970  0.497
2015 Li L, Zhang Y, Fan Y, Sun K, Su X, Du Z, Tsao SW, Loh TK, Sun H, Chan AT, Zeng YX, Chan WY, Chan FK, Tao Q. Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes. Epigenomics. 7: 155-73. PMID 25479246 DOI: 10.2217/Epi.14.79  0.779
2015 Han Y, Zheng YL, Fan YP, Liu MH, Lu XY, Tao Q. Association of adiponectin gene polymorphism 45TG with gestational diabetes mellitus diagnosed on the new IADPSG criteria, plasma adiponectin levels and adverse pregnancy outcomes. Clinical and Experimental Medicine. 15: 47-53. PMID 24664457 DOI: 10.1007/s10238-014-0275-8  0.64
2015 Li X, Yu J, Brock M, Tao Q, Herman J, Liang P, Guo M. Abstract 2950: Epigenetic silencing BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU Cancer Research. 75: 2950-2950. DOI: 10.1158/1538-7445.Am2015-2950  0.402
2015 Zhang L, Fan Y, Li L, Wang Z, Zhang Q, Tao Q, Jin J. Mp55-10 Epigenetic Regulation Of The 3P22 Tumor Suppressor Dlec1 In Human Prostate Cancer Associated With Its Prognosis The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2053  0.435
2015 Wang L, Zhang Q, Zhang L, Xiang T, Fan Y, Xu B, Tao Q, Jin J. Mp47-08 The Methylation Of Sox7 And Its Function As A Tumor Suppressor In Renal Cell Cancer The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1528  0.519
2014 Sung FL, Cui Y, Hui EP, Li L, Loh TK, Tao Q, Chan AT. Silencing of hypoxia-inducible tumor suppressor lysyl oxidase gene by promoter methylation activates carbonic anhydrase IX in nasopharyngeal carcinoma. American Journal of Cancer Research. 4: 789-800. PMID 25520868  0.519
2014 Xiao Y, Xiang T, Luo X, Li C, Li Q, Peng W, Li L, Li S, Wang Z, Tang L, Ren G, Tao Q. Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer. Plos One. 9: e110990. PMID 25360542 DOI: 10.1371/Journal.Pone.0110990  0.533
2014 Li L, Zhang Y, Guo BB, Chan FK, Tao Q. Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cells. Chinese Journal of Cancer. 33: 604-8. PMID 25322866 DOI: 10.5732/Cjc.014.10191  0.541
2014 Tong X, Li L, Li X, Heng L, Zhong L, Su X, Rong R, Hu S, Liu W, Jia B, Liu X, Kou G, Han J, Guo S, Hu Y, ... ... Tao Q, et al. SOX10, a novel HMG-box-containing tumor suppressor, inhibits growth and metastasis of digestive cancers by suppressing the Wnt/β-catenin pathway. Oncotarget. 5: 10571-83. PMID 25301735 DOI: 10.18632/Oncotarget.2512  0.561
2014 Zhang Q, Zhang L, Li L, Wang Z, Ying J, Fan Y, Xu B, Wang L, Liu Q, Chen G, Tao Q, Jin J. Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis. Cancer Letters. 354: 227-34. PMID 25109451 DOI: 10.1016/J.Canlet.2014.07.040  0.838
2014 Wang Y, Lei R, Zhuang X, Zhang N, Pan H, Li G, Hu J, Pan X, Tao Q, Fu D, Xiao J, Chin YE, Kang Y, Yang Q, Hu G. DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis. The Journal of Clinical Investigation. 124: 1646-59. PMID 24590291 DOI: 10.1172/Jci71812  0.363
2014 Choi GC, Li J, Wang Y, Li L, Zhong L, Ma B, Su X, Ying J, Xiang T, Rha SY, Yu J, Sung JJ, Tsao SW, Chan AT, Tao Q. The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation. Molecular Cancer Research : McR. 12: 228-38. PMID 24184540 DOI: 10.1158/1541-7786.Mcr-13-0195  0.734
2014 Li L, Ying J, Tong X, Zhong L, Su X, Xiang T, Shu X, Rong R, Xiong L, Li H, Chan AT, Ambinder RF, Guo Y, Tao Q. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas. Cellular and Molecular Life Sciences : Cmls. 71: 2179-92. PMID 24158497 DOI: 10.1007/S00018-013-1485-Z  0.794
2014 Li H, Li J, Su Y, Fan Y, Guo X, Li L, Su X, Rong R, Ying J, Mo X, Liu K, Zhang Z, Yang F, Jiang G, Wang J, ... ... Tao Q, et al. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth. Oncogene. 33: 3109-18. PMID 23893243 DOI: 10.1038/Onc.2013.282  0.839
2013 Tan Q, Wang G, Huang J, Ding Z, Luo Q, Mok T, Tao Q, Lu S. Epigenomic analysis of lung adenocarcinoma reveals novel DNA methylation patterns associated with smoking. Oncotargets and Therapy. 6: 1471-9. PMID 24204162 DOI: 10.2147/Ott.S51041  0.357
2013 Xiang T, Li L, Yin X, Zhong L, Peng W, Qiu Z, Ren G, Tao Q. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells. Journal of Cellular and Molecular Medicine. 17: 1236-46. PMID 23890219 DOI: 10.1111/Jcmm.12099  0.431
2013 Qiao B, Chen Z, Hu F, Tao Q, Lam AK. BMI-1 activation is crucial in hTERT-induced epithelial-mesenchymal transition of oral epithelial cells. Experimental and Molecular Pathology. 95: 57-61. PMID 23712029 DOI: 10.1016/j.yexmp.2013.05.004  0.305
2013 Shu XS, Li L, Ji M, Cheng Y, Ying J, Fan Y, Zhong L, Liu X, Tsao SW, Chan AT, Tao Q. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Carcinogenesis. 34: 1984-93. PMID 23677067 DOI: 10.1093/Carcin/Bgt165  0.854
2013 Su X, Wang Z, Li L, Zheng M, Zheng C, Gong P, Zhao P, Ma Y, Tao Q, Cai L. Lipid-polymer nanoparticles encapsulating doxorubicin and 2'-deoxy-5-azacytidine enhance the sensitivity of cancer cells to chemical therapeutics. Molecular Pharmaceutics. 10: 1901-9. PMID 23570548 DOI: 10.1021/Mp300675C  0.383
2013 Yin X, Xiang T, Li L, Su X, Shu X, Luo X, Huang J, Yuan Y, Peng W, Oberst M, Kelly K, Ren G, Tao Q. DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer. Breast Cancer Research : Bcr. 15: R23. PMID 23497530 DOI: 10.1186/Bcr3399  0.618
2013 Wang J, Xia Y, Li L, Gong D, Yao Y, Luo H, Lu H, Yi N, Wu H, Zhang X, Tao Q, Gao F. Double restriction-enzyme digestion improves the coverage and accuracy of genome-wide CpG methylation profiling by reduced representation bisulfite sequencing. Bmc Genomics. 14: 11. PMID 23324053 DOI: 10.1186/1471-2164-14-11  0.322
2013 Kim do N, Seo MK, Choi H, Kim SY, Shin HJ, Yoon AR, Tao Q, Rha SY, Lee SK. Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1. The Journal of General Virology. 94: 497-506. PMID 23175241 DOI: 10.1099/Vir.0.045237-0  0.395
2013 Liu X, Wang Y, Wang X, Sun Z, Li L, Tao Q, Luo B. Epigenetic silencing of WNT5A in Epstein-Barr virus-associated gastric carcinoma. Archives of Virology. 158: 123-32. PMID 23001722 DOI: 10.1007/s00705-012-1481-x  0.454
2013 Hu X, Sui X, Li L, Huang X, Rong R, Su X, Shi Q, Mo L, Shu X, Kuang Y, Tao Q, He C. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. The Journal of Pathology. 229: 62-73. PMID 22926751 DOI: 10.1002/Path.4093  0.654
2013 Du W, Wang S, Zhou Q, Li X, Chu J, Chang Z, Tao Q, Ng EK, Fang J, Sung JJ, Yu J. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene. 32: 3319-28. PMID 22907434 DOI: 10.1038/Onc.2012.359  0.53
2013 Wang S, Cheng Y, Du W, Lu L, Zhou L, Wang H, Kang W, Li X, Tao Q, Sung JJ, Yu J. Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer. Gut. 62: 833-41. PMID 22580414 DOI: 10.1136/Gutjnl-2011-301776  0.448
2013 Li JS, Ying JM, Wang XW, Wang ZH, Tao Q, Li LL. Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma. Chinese Journal of Cancer. 32: 3-11. PMID 22572016 DOI: 10.5732/Cjc.011.10381  0.716
2013 Yu J, Liang QY, Wang J, Cheng Y, Wang S, Poon TC, Go MY, Tao Q, Chang Z, Sung JJ. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer. Oncogene. 32: 307-17. PMID 22370639 DOI: 10.1038/Onc.2012.54  0.549
2013 Xiang TX, Yuan Y, Li LL, Wang ZH, Dan LY, Chen Y, Ren GS, Tao Q. Aberrant promoter CpG methylation and its translational applications in breast cancer. Chinese Journal of Cancer. 32: 12-20. PMID 22059908 DOI: 10.5732/Cjc.011.10344  0.475
2013 Hsieh WS, Tan EH, Lim W, Soo RA, Chan ATC, Hui EP, Lee S, Low JSW, Lim PL, Loh TKS, Ames MM, Reid JM, Murray PG, Tao Q, Goh BC, et al. A phase IB trial of 5-azacitidine (5AC) and suberoylanilide hydroxamic acid (SAHA) in patients with metastatic or locally recurrent nasopharyngeal carcinoma (NPC) and NK-T cell lymphoma. Journal of Clinical Oncology. 31: e17017-e17017. DOI: 10.1200/Jco.2013.31.15_Suppl.E17017  0.386
2012 Vrzalikova K, Leonard S, Fan Y, Bell A, Vockerodt M, Flodr P, Wright KL, Rowe M, Tao Q, Murray PG. Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas. Pathogens (Basel, Switzerland). 1: 83-101. PMID 25436766 DOI: 10.3390/Pathogens1020083  0.728
2012 Shu XS, Li L, Tao Q. Chromatin regulators with tumor suppressor properties and their alterations in human cancers. Epigenomics. 4: 537-49. PMID 23130835 DOI: 10.2217/Epi.12.50  0.688
2012 Wang S, Kang W, Go MY, Tong JH, Li L, Zhang N, Tao Q, Li X, To KF, Sung JJ, Yu J. Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-κB signaling pathway. Molecular Medicine (Cambridge, Mass.). 18: 1402-11. PMID 23073659 DOI: 10.2119/Molmed.2012.00243  0.561
2012 Wang Z, Li L, Su X, Gao Z, Srivastava G, Murray PG, Ambinder R, Tao Q. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas. Journal of Translational Medicine. 10: 209. PMID 23050586 DOI: 10.1186/1479-5876-10-209  0.553
2012 Yeo W, Chung HC, Chan SL, Wang LZ, Lim R, Picus J, Boyer M, Mo FK, Koh J, Rha SY, Hui EP, Jeung HC, Roh JK, Yu SC, To KF, ... Tao Q, et al. Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3361-7. PMID 22915658 DOI: 10.1200/Jco.2011.41.2395  0.33
2012 Fok KL, Chung CM, Yi SQ, Jiang X, Sun X, Chen H, Chen YC, Kung HF, Tao Q, Diao R, Chan H, Zhang XH, Chung YW, Cai Z, Chang Chan H. STK31 maintains the undifferentiated state of colon cancer cells. Carcinogenesis. 33: 2044-53. PMID 22828137 DOI: 10.1093/Carcin/Bgs246  0.413
2012 Chu Z, Huang Y, Li L, Tao Q, Li Q. Physiological pathway of human cell damage induced by genotoxic crystalline silica nanoparticles. Biomaterials. 33: 7540-6. PMID 22795858 DOI: 10.1016/J.Biomaterials.2012.06.073  0.318
2012 Ying J, Shan L, Li J, Zhong L, Xue L, Zhao H, Li L, Langford C, Guo L, Qiu T, Lu N, Tao Q. Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis. Plos One. 7: e39797. PMID 22761904 DOI: 10.1371/Journal.Pone.0039797  0.618
2012 Chen H, Ko JM, Wong VC, Hyytiainen M, Keski-Oja J, Chua D, Nicholls JM, Cheung FM, Lee AW, Kwong DL, Chiu PM, Zabarovsky ER, Tsao SW, Tao Q, Kan R, et al. LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. Cancer Letters. 325: 89-98. PMID 22743615 DOI: 10.1016/J.Canlet.2012.06.005  0.526
2012 Li L, Li W, Xiao L, Xu J, Chen X, Tang M, Dong Z, Tao Q, Cao Y. Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53. Cell Cycle (Georgetown, Tex.). 11: 2327-36. PMID 22684299 DOI: 10.4161/Cc.20771  0.418
2012 Cheng Y, Liang P, Geng H, Wang Z, Li L, Cheng SH, Ying J, Su X, Ng KM, Ng MH, Mok TS, Chan AT, Tao Q. A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomas. Molecular Cancer Research : McR. 10: 925-36. PMID 22679109 DOI: 10.1158/1541-7786.Mcr-11-0594  0.735
2012 Li L, Su X, Choi GC, Cao Y, Ambinder RF, Tao Q. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins. Bmc Cancer. 12: 125. PMID 22458933 DOI: 10.1186/1471-2407-12-125  0.51
2012 Xiang T, Li L, Yin X, Yuan C, Tan C, Su X, Xiong L, Putti TC, Oberst M, Kelly K, Ren G, Tao Q. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer. Plos One. 7: e29783. PMID 22279545 DOI: 10.1371/Journal.Pone.0029783  0.495
2012 Li L, Ying J, Li H, Zhang Y, Shu X, Fan Y, Tan J, Cao Y, Tsao SW, Srivastava G, Chan ATC, Tao Q. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/Β-catenin signaling and silenced in common carcinomas Oncogene. 31: 3901-3912. PMID 22139084 DOI: 10.1038/Onc.2011.541  0.846
2012 Li X, Cheung KF, Ma X, Tian L, Zhao J, Go MYY, Shen B, Cheng ASL, Ying J, Tao Q, Sung JJY, Kung HF, Yu J. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients Oncogene. 31: 3419-3430. PMID 22105368 DOI: 10.1038/Onc.2011.511  0.719
2012 Xu L, Li X, Chu ES, Zhao G, Go MY, Tao Q, Jin H, Zeng Z, Sung JJ, Yu J. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival. Gut. 61: 977-85. PMID 21917650 DOI: 10.1136/Gutjnl-2011-300411  0.522
2012 Du W, Wang S, Li X, Tao Q, Fang J, Sung JJ, Yu J. Su1861 A Disintegrin-Like and Metalloprotease With Thrombospondin Type 1 Motif 9 is a Functional Tumor Suppressor in Gastric Cancer Through Inhibiting AKT/mTOR Pathway Gastroenterology. 142: S-521. DOI: 10.1016/S0016-5085(12)62000-9  0.371
2012 Wang S, Du W, Li X, Tao Q, Sung JJ, Yu J. 56 Zinc Finger Protein 545 is a Functional Tumor Suppressor Through Inhibiting Ribosomal RNA Transcription in Gastric Cancer Gastroenterology. 142: S-15. DOI: 10.1016/S0016-5085(12)60056-0  0.456
2011 Shu XS, Geng H, Li L, Ying J, Ma C, Wang Y, Poon FF, Wang X, Ying Y, Yeo W, Srivastava G, Tsao SW, Yu J, Sung JJ, Huang S, ... ... Tao Q, et al. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors. Plos One. 6: e27346. PMID 22087297 DOI: 10.1371/Journal.Pone.0027346  0.818
2011 Qiao B, Johnson NW, Chen X, Li R, Tao Q, Gao J. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition. Oncology Reports. 26: 455-61. PMID 21567100 DOI: 10.3892/or.2011.1299  0.34
2011 Li LL, Shu XS, Wang ZH, Cao Y, Tao Q. Epigenetic disruption of cell signaling in nasopharyngeal carcinoma. Chinese Journal of Cancer. 30: 231-9. PMID 21439244 DOI: 10.5732/Cjc.011.10080  0.682
2011 Liu W, Li X, Chu ES, Go MY, Xu L, Zhao G, Li L, Dai N, Si J, Tao Q, Sung JJ, Yu J. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology (Baltimore, Md.). 53: 843-53. PMID 21319196 DOI: 10.1002/Hep.24124  0.541
2011 Low JS, Tao Q, Ng KM, Goh HK, Shu XS, Woo WL, Ambinder RF, Srivastava G, Shamay M, Chan AT, Popescu NC, Hsieh WS. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors. Oncogene. 30: 1923-35. PMID 21217778 DOI: 10.1038/Onc.2010.576  0.763
2011 Chan SH, Yee Ko JM, Chan KW, Chan YP, Tao Q, Hyytiainen M, Keski-Oja J, Law S, Srivastava G, Tang J, Tsao SW, Chen H, Stanbridge EJ, Lung ML. The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome. International Journal of Cancer. Journal International Du Cancer. 129: 565-73. PMID 20878956 DOI: 10.1002/Ijc.25698  0.552
2011 Loyo M, Brait M, Kim MS, Ostrow KL, Jie CC, Chuang AY, Califano JA, Liégeois NJ, Begum S, Westra WH, Hoque MO, Tao Q, Sidransky D. A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 128: 1393-403. PMID 20473931 DOI: 10.1002/Ijc.25443  0.552
2011 Chen Y, Guo T, Shen L, Wong K, Au W, Tao Q, Wong L, Tang C, Choi WL, Liu W, Li G, Shimizu N, Tsuchiyama J, Loong F, Liang R, et al. Epigenetic Silencing of the Receptor Tyrosine Phosphatase, PTPRK, Located At the Frequently Deleted 6q22.33-q23.2 Region, Leads to Tumor Growth Via the Constitutive Activation of STAT3 in Nasal-Type NK/T-Cell Lymphoma Blood. 118: 1378-1378. DOI: 10.1182/Blood.V118.21.1378.1378  0.544
2011 Fan Y, Ying Y, Li L, Chan AT, Tao Q. Abstract 2191: The Wnt/DVL signaling antagonist DACT2 is a pro-apoptotic tumor suppressor epigenetically silenced in multiple tumors and inhibits tumor cell proliferation and migration Cancer Research. 71: 2191-2191. DOI: 10.1158/1538-7445.Am2011-2191  0.805
2011 Choi GC, Wang Y, Li J, Li L, Ying J, Ma BB, Tao Q, Chan AT. Abstract 2190:ADAMTS8at 11q25 is a tumor suppressor antagonizing Ras-signaling and methylated in multiple carcinomas Cancer Research. 71: 2190-2190. DOI: 10.1158/1538-7445.Am2011-2190  0.734
2011 Yu J, Wang J, Liang Q, Cheung K, Wang S, Go MY, Tao Q, Sung JJ. Zinc Finger Protein 331, a Novel Putative Tumor Suppressor, Suppresses Growth and Invasiveness of Gastric Cancer Cells Gastroenterology. 140: S-818-S-819. DOI: 10.1016/S0016-5085(11)63388-X  0.467
2011 Wang S, Go MY, Chu ES, Cheung K, Li X, Kang W, Tong JH, Tao Q, To KF, Sung JJ, Yu J. DACT1 is Silenced by CpG Methylation in Gastric Cancer and Contributes to the Pathogenesis of Gastric Cancer Gastroenterology. 140: S-157. DOI: 10.1016/S0016-5085(11)60637-9  0.358
2011 Xu L, Li X, Chu ES, Zhao G, Go MY, Zeng Z, Tao Q, Sung JJ, Yu J. Epigenetic Inactivation of BCL6B, a Functional Tumor Suppressor for Gastric Cancer, is Associated With Poor Survival of Gastric Cancer Gastroenterology. 140: S-157. DOI: 10.1016/S0016-5085(11)60636-7  0.435
2011 Li X, Liu W, Cheung K, Chu ES, Tao Q, Sung JJ, Yu J. Epigenetic Characterization of RAS Association Domain-Containing Protein 10 as a Functional Tumor Suppressor in Gastric Cancer Gastroenterology. 140: S-144-S-145. DOI: 10.1016/S0016-5085(11)60588-X  0.315
2010 Murray PG, Fan Y, Davies G, Ying J, Geng H, Ng KM, Li H, Gao Z, Wei W, Bose S, Anderton J, Kapatai G, Reynolds G, Ito A, Marafioti T, ... ... Tao Q, et al. Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis. The American Journal of Pathology. 177: 1480-90. PMID 20709797 DOI: 10.2353/Ajpath.2010.100052  0.815
2010 Cheng Y, Geng H, Cheng SH, Liang P, Bai Y, Li J, Srivastava G, Ng MH, Fukagawa T, Wu X, Chan AT, Tao Q. KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. Cancer Research. 70: 6516-26. PMID 20682794 DOI: 10.1158/0008-5472.Can-09-4566  0.59
2010 Xiang T, Li L, Fan Y, Jiang Y, Ying Y, Putti TC, Tao Q, Ren G. PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer. Cancer Biology & Therapy. 10: 520-7. PMID 20657189 DOI: 10.4161/Cbt.10.5.12726  0.789
2010 Zhang Q, Ying J, Li J, Fan Y, Poon FF, Ng KM, Tao Q, Jin J. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage. The Journal of Urology. 184: 731-7. PMID 20639048 DOI: 10.1016/J.Juro.2010.03.108  0.829
2010 Li J, Ying J, Fan Y, Wu L, Ying Y, Chan AT, Srivastava G, Tao Q. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biology & Therapy. 10: 617-24. PMID 20603606 DOI: 10.4161/Cbt.10.6.12609  0.83
2010 Li L, Tao Q, Jin H, van Hasselt A, Poon FF, Wang X, Zeng MS, Jia WH, Zeng YX, Chan AT, Cao Y. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2949-58. PMID 20395212 DOI: 10.1158/1078-0432.Ccr-09-3178  0.432
2010 Fu L, Dong SS, Xie YW, Tai LS, Chen L, Kong KL, Man K, Xie D, Li Y, Cheng Y, Tao Q, Guan XY. Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma. Hepatology (Baltimore, Md.). 51: 1624-34. PMID 20209601 DOI: 10.1002/Hep.23540  0.464
2010 Ma BB, Lui VW, Poon FF, Wong SC, To KF, Wong E, Chen H, Lo KW, Tao Q, Chan AT, Ng MH, Cheng SH. Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response. Investigational New Drugs. 28: 326-33. PMID 19756373 DOI: 10.1007/S10637-009-9316-7  0.39
2010 Cheng Y, Liang P, Geng H, Cheng SH, Ng MHL, Chan ATc, Tao Q. Abstract 197: The KRAB-containing zinc finger protein ZNF545 is a functional tumor suppressor exerting proapoptotic and antiproliferation abilities with frequent epigenetic inactivation in multiple carcinomas Cancer Research. 70: 197-197. DOI: 10.1158/1538-7445.Am10-197  0.616
2010 Leung CH, Ng KM, Wong AHY, Ying Jm, Srivastava G, Leung SF, Chan ATC, Tao Q. Abstract 195: Functional epigenetics identifies a protein phosphatase-1 regulatory subunit gene as a candidate tumor suppressor frequently silenced by promoter CpG methylation in multiple tumors Cellular and Molecular Biology. 70: 195-195. DOI: 10.1158/1538-7445.Am10-195  0.532
2010 Low JSW, Tao Q, Goh HK, Ng KM, Woo WL, Ambinder RF, Srivastava G, Shamay M, Chan ATC, Popescu NC, Hsieh W. Abstract B33: A novel isoform of the major 8p22 tumor suppressor Deleted in Liver Cancer 1 (DLC1) gene with growth suppression function is frequently silenced epigenetically in multiple tumors Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcme10-B33  0.614
2010 Li X, Cheung K, Zhao J, Ma X, Go MY, Chu ES, Cheng AS, Tao Q, Sung JJ, Kung H, Yu J. 22 Epigenetic Identification of Paired Box Gene 5 as a Functional Tumor Suppressor Associated With Poor Prognosis in Patients With Gastric Cancer Gastroenterology. 138: S-4. DOI: 10.1016/S0016-5085(10)60016-9  0.475
2010 Ma BB, Lui VW, Poon FF, Wong CS, To KF, Wong E, Chen H, Lo KW, Tao Q, Ng MHL, Cheng SH, Chan AT. Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7) Investigational New Drugs. 28. DOI: 10.1007/S10637-010-9397-3  0.324
2009 Ying Y, Tao Q. Epigenetic disruption of the WNT/ß-catenin signaling pathway in human cancers. Epigenetics. 4: 307-312. PMID 28001119 DOI: 10.4161/epi.4.5.9371  0.357
2009 Narayan G, Scotto L, Neelakantan V, Kottoor SH, Wong AH, Loke SL, Mansukhani M, Pothuri B, Wright JD, Kaufmann AM, Schneider A, Arias-Pulido H, Tao Q, Murty VV. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes, Chromosomes & Cancer. 48: 983-92. PMID 19681120 DOI: 10.1002/Gcc.20703  0.49
2009 Ying Y, Tao Q. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers Epigenetics : Official Journal of the Dna Methylation Society. 4: 307-312. PMID 19633433  0.303
2009 Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q, Choi GC, Au TC, Ho K, Yau DM, Ma BB, Hui EP, Chan AS, Tsang CM, Tsao SW, et al. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. International Journal of Cancer. Journal International Du Cancer. 125: 1884-93. PMID 19588483 DOI: 10.1002/Ijc.24567  0.419
2009 Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H, Li H, Shu XS, Li H, Liu W, Luo B, Zhang Q, Mok TS, Zheng W, Qiu X, ... ... Tao Q, et al. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Cancer Research. 69: 5194-201. PMID 19509237 DOI: 10.1158/0008-5472.Can-08-3694  0.764
2009 Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, Shi QL, Tang HM, Fu L, Guan XY, Rha SY, Tao Q, He C. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Oncogene. 28: 2466-75. PMID 19448674 DOI: 10.1038/Onc.2009.92  0.832
2009 Ma BB, Sung F, Tao Q, Poon FF, Lui VW, Yeo W, Chan SL, Chan AT. The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines. Investigational New Drugs. 28: 107-14. PMID 19172229 DOI: 10.1007/S10637-009-9219-7  0.462
2009 Ying J, Poon FF, Yu J, Geng H, Wong AH, Qiu GH, Goh HK, Rha SY, Tian L, Chan AT, Sung JJ, Tao Q. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers. British Journal of Cancer. 100: 663-9. PMID 19156137 DOI: 10.1038/Sj.Bjc.6604888  0.666
2009 Fu L, Gao Z, Zhang X, Tsang YH, Goh HK, Geng H, Shimizu N, Tsuchiyama J, Srivastava G, Tao Q. Frequent concomitant epigenetic silencing of the stress-responsive tumor suppressor gene CADM1, and its interacting partner DAL-1 in nasal NK/T-cell lymphoma. International Journal of Cancer. 124: 1572-8. PMID 19115211 DOI: 10.1002/Ijc.24123  0.568
2009 Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, Jin H, To KF, Chan FK, Sung JJ. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology. 136: 640-51.e1. PMID 19084528 DOI: 10.1053/J.Gastro.2008.10.050  0.672
2009 Yu J, Tao Q, Cheng YY, Lee KY, Ng SS, Cheung KF, Tian L, Rha SY, Neumann U, Röcken C, Ebert MP, Chan FK, Sung JJ. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer. 115: 49-60. PMID 19051296 DOI: 10.1002/Cncr.23989  0.415
2009 Cui L, Xu LY, Shen ZY, Tao Q, Gao SY, Lv Z, Du ZP, Fang WK, Li EM. NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7674-81. PMID 19047093 DOI: 10.1158/1078-0432.Ccr-08-0420  0.465
2009 Zhang Q, Jin J, Tao Q. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma]. Ai Zheng = Aizheng = Chinese Journal of Cancer. 26: 1276-80. PMID 17991333  0.445
2008 Cui Y, Ying Y, van Hasselt A, Ng KM, Yu J, Zhang Q, Jin J, Liu D, Rhim JS, Rha SY, Loyo M, Chan AT, Srivastava G, Tsao GS, Sellar GC, ... ... Tao Q, et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. Plos One. 3: e2990. PMID 18714356 DOI: 10.1371/Journal.Pone.0002990  0.538
2008 Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, Li H, Cheng YY, Röcken C, Ebert MPA, Chan ATC, Sung JJY. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors Hepatology. 48: 508-518. PMID 18666234 DOI: 10.1002/Hep.22343  0.569
2008 Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, Cao Y, Zeng YX, Wong AH, Wang X, Ying J, Srivastava G, Lung ML, Wang LD, Kwok TT, Levi BZ, ... ... Tao Q, et al. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene. 27: 5267-76. PMID 18469857 DOI: 10.1038/Onc.2008.147  0.711
2008 Chan SY, Choy KW, Tsao SW, Tao Q, Tang T, Chung GT, Lo KW. Authentication of nasopharyngeal carcinoma tumor lines. International Journal of Cancer. Journal International Du Cancer. 122: 2169-71. PMID 18196576 DOI: 10.1002/Ijc.23374  0.45
2008 Qiu GH, Salto-Tellez M, Ross JA, Yeo W, Cui Y, Wheelhouse N, Chen GG, Harrison D, Lai P, Tao Q, Hooi SC. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle Journal of Hepatology. 48: 433-441. PMID 18191269 DOI: 10.1016/J.Jhep.2007.11.015  0.6
2008 Ying J, Li H, Yu J, Ng KM, Poon FF, Wong SC, Chan AT, Sung JJ, Tao Q. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 55-61. PMID 18172252 DOI: 10.1158/1078-0432.Ccr-07-1644  0.623
2008 Jin B, Tao Q, Peng J, Soo HM, Wu W, Ying J, Fields CR, Delmas AL, Liu X, Qiu J, Robertson KD. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Human Molecular Genetics. 17: 690-709. PMID 18029387 DOI: 10.1093/Hmg/Ddm341  0.621
2008 Yu J, Cheng YY, Tao Q, Wong YP, Tian L, Jin H, Leung WK, Chan FK, Sung JJ. M1619 Methylated Protocadherin 10 Is Identified As a Target of Epigenetic Silencing and a Prognostic Predictor in Gastric Cancer Gastroenterology. 134: A-383. DOI: 10.1016/S0016-5085(08)61789-8  0.393
2008 Yu J, Tao Q, Jin H, Poon FF, Wang X, Li H, Cheng YY, Ebert MP, Röcken C, Chan AW, Sung JJ. M1616 Functional Significance of a Putative Tumor Suppressor, the Ubiquitin Carboxyl-Terminal Hydrolase L1 Gene, in Multiple Digestive Tumors Gastroenterology. 134: A-383. DOI: 10.1016/S0016-5085(08)61786-2  0.419
2008 Yu J, Tao Q, Cheng YY, Tian L, Cheung KF, Sung JJ. M1615 Aberrant Methylation of Dkk-3 in Gastric Cancer Associated with Poor Outcome Gastroenterology. 134: A-382-A-383. DOI: 10.1016/S0016-5085(08)61785-0  0.353
2008 Cheng YD, Bai Y, Wong AH, Liang P, Li JS, Ying JM, Cao Y, Chan AT, Wu X, Tao Q. The KRAB domain-containing zinc finger protein ZNF382 is a potent tumor suppressor with frequent epigenetic inactivation in nasopharyngeal, esophageal and other carcinomas Cell Biology International. 32: S5-S5. DOI: 10.1016/J.Cellbi.2008.01.026  0.453
2008 Tao Q. Integrative cancer epigenetics identifies novel tumor suppressor genes for common asian tumors Cell Biology International. 32: S4-S4. DOI: 10.1016/j.cellbi.2008.01.023  0.402
2007 Ying J, Li H, Chen YW, Srivastava G, Gao Z, Tao Q. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood. 110: 4130-2. PMID 18024799 DOI: 10.1182/Blood-2007-06-094870  0.653
2007 Ying J, Li H, Murray P, Gao Z, Chen YW, Wang Y, Lee KY, Chan AT, Ambinder RF, Srivastava G, Tao Q. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas. Epigenetics. 2: 15-21. PMID 17965626 DOI: 10.4161/Epi.2.1.3883  0.711
2007 Tedoldi S, Mottok A, Ying J, Paterson JC, Cui Y, Facchetti F, van Krieken JH, Ponzoni M, Ozkal S, Masir N, Natkunam Y, Pileri S, Hansmann ML, Mason D, Tao Q, et al. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. The Journal of Pathology. 213: 429-40. PMID 17935142 DOI: 10.1002/Path.2242  0.585
2007 Shao L, Cui Y, Li H, Liu Y, Zhao H, Wang Y, Zhang Y, Ng KM, Han W, Ma D, Tao Q. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5756-62. PMID 17908965 DOI: 10.1158/1078-0432.Ccr-06-3082  0.555
2007 Bose S, Starczynski J, Chukwuma M, Baumforth K, Wei W, Morgan S, Byrd P, Ying J, Grundy R, Mann JR, Tao Q, Taylor AM, Murray PG, Stankovic T. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation. The Journal of Pathology. 213: 329-36. PMID 17876757 DOI: 10.1002/Path.2232  0.607
2007 Cheng YY, Yu J, Wong YP, Man EP, To KF, Jin VX, Li J, Tao Q, Sung JJ, Chan FK, Leung WK. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. British Journal of Cancer. 97: 895-901. PMID 17848950 DOI: 10.1038/Sj.Bjc.6603968  0.423
2007 Jin H, Wang X, Ying J, Wong AH, Cui Y, Srivastava G, Shen ZY, Li EM, Zhang Q, Jin J, Kupzig S, Chan AT, Cullen PJ, Tao Q. Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers. Proceedings of the National Academy of Sciences of the United States of America. 104: 12353-8. PMID 17640920 DOI: 10.1073/Pnas.0700153104  0.571
2007 Jin H, Wang X, Ying J, Wong AH, Li H, Lee KY, Srivastava G, Chan AT, Yeo W, Ma BB, Putti TC, Lung ML, Shen ZY, Xu LY, Langford C, ... Tao Q, et al. Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas. Oncogene. 26: 7490-8. PMID 17546048 DOI: 10.1038/Sj.Onc.1210559  0.723
2007 Tao Q, Chan AT. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Reviews in Molecular Medicine. 9: 1-24. PMID 17477889 DOI: 10.1017/S1462399407000312  0.368
2007 Law FB, Chen YW, Wong KY, Ying J, Tao Q, Langford C, Lee PY, Law S, Cheung RW, Chui CH, Tsao SW, Lam KY, Wong J, Srivastava G, Tang JC. Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma. Oncogene. 26: 5877-88. PMID 17384685 DOI: 10.1038/Sj.Onc.1210390  0.65
2007 Chan SL, Cui Y, van Hasselt A, Li H, Srivastava G, Jin H, Ng KM, Wang Y, Lee KY, Tsao GS, Zhong S, Robertson KD, Rha SY, Chan AT, Tao Q. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Laboratory Investigation; a Journal of Technical Methods and Pathology. 87: 644-50. PMID 17384664 DOI: 10.1038/Labinvest.3700547  0.629
2007 Ying J, Gao Z, Li H, Srivastava G, Murray PG, Goh HK, Lim CY, Wang Y, Marafioti T, Mason DY, Ambinder RF, Chan AT, Tao Q. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. British Journal of Haematology. 136: 829-32. PMID 17341268 DOI: 10.1111/J.1365-2141.2007.06512.X  0.649
2007 Sung FL, Hui EP, Tao Q, Li H, Tsui NB, Lo YM, Ma BB, To KF, Harris AL, Chan AT. Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma. Cancer Letters. 253: 74-88. PMID 17320280 DOI: 10.1016/J.Canlet.2007.01.012  0.4
2007 Zhang Q, Ying J, Zhang K, Li H, Ng KM, Zhao Y, He Q, Yang X, Xin D, Liao SK, Tao Q, Jin J. Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma. Cancer Letters. 249: 220-6. PMID 17029774 DOI: 10.1016/J.Canlet.2006.08.019  0.698
2007 Seng TJ, Low JSW, Li H, Cui Y, Goh HK, Wong MLY, Srivastava G, Sidransky D, Califano J, Steenbergen RDM, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, ... ... Tao Q, et al. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation Oncogene. 26: 934-944. PMID 16862168 DOI: 10.1038/Sj.Onc.1209839  0.614
2007 Lee S, Mok T, Li H, Yim A, Wan I, Lam KC, Chan A, To KF, Tao Q. Possible correlation between SOCS1 methylation and EGFR exon 19 mutation but not exon 21 mutation in Chinese NSCLC patients Journal of Clinical Oncology. 25: 18113-18113. DOI: 10.1200/Jco.2007.25.18_Suppl.18113  0.443
2007 Soo R, Wu J, Aggarwal A, Tao Q, Hsieh W, Putti T, Tan K, Soon W, Lai Y, Mow B, Hsu S, Loh K, Tan L, Tan P, Goh B. Correction to: Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression. Ann Oncol 2006; 17: 1625–1630 Annals of Oncology. 18: 611. DOI: 10.1093/Annonc/Mdm054  0.331
2006 Soo RA, Wu J, Aggarwal A, Tao Q, Hsieh W, Putti T, Tan KB, Soon WL, Lai YF, Mow B, Hsu S, Loh KS, Tan L, Tan P, Goh BC. Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression Annals of Oncology. 17: 1625-1630. PMID 17008411 DOI: 10.1093/Annonc/Mdl283  0.473
2006 Chen YW, Hu XT, Liang AC, Au WY, So CC, Wong ML, Shen L, Tao Q, Chu KM, Kwong YL, Liang RH, Srivastava G. High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma. Blood. 108: 2373-83. PMID 16772602 DOI: 10.1182/Blood-2006-05-022517  0.359
2006 Tao Q, Young LS, Woodman CB, Murray PG. Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics. Frontiers in Bioscience : a Journal and Virtual Library. 11: 2672-713. PMID 16720343 DOI: 10.2741/2000  0.427
2006 Ying J, Li H, Cui Y, Wong AH, Langford C, Tao Q. Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter. Leukemia. 20: 1173-5. PMID 16572203 DOI: 10.1038/Sj.Leu.2404193  0.628
2006 Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis. 27: 1341-8. PMID 16501252 DOI: 10.1093/Carcin/Bgi379  0.49
2006 Wong ML, Tao Q, Fu L, Wong KY, Qiu GH, Law FB, Tin PC, Cheung WL, Lee PY, Tang JC, Tsao GS, Lam KY, Law S, Wong J, Srivastava G. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. International Journal of Oncology. 28: 767-73. PMID 16465383  0.425
2006 Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan ATC, Tao Q. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation Oncogene. 25: 1070-1080. PMID 16247458 DOI: 10.1038/Sj.Onc.1209154  0.687
2006 Wong MLY, Tao Q, Fu LI, Wong KY, Qiu GH, Law FBF, Tin PC, Cheung WL, Lee PY, Tang JCO, Tsao GSW, Lam KY, Law S, Wong J, Srivastava G. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma International Journal of Oncology. 28: 767-773. DOI: 10.3892/Ijo.28.3.767  0.519
2005 Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors Clinical Cancer Research. 11: 6442-6449. PMID 16166418 DOI: 10.1158/1078-0432.Ccr-05-0267  0.715
2005 Doerr JR, Malone CS, Fike FM, Gordon MS, Soghomonian SV, Thomas RK, Tao Q, Murray PG, Diehl V, Teitell MA, Wall R. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines. Journal of Molecular Biology. 350: 631-40. PMID 15967459 DOI: 10.1016/J.Jmb.2005.05.032  0.472
2005 Soo R, Putti T, Tao Q, Goh BC, Lee KH, Kwok-Seng L, Tan L, Hsieh WS. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. Archives of Otolaryngology--Head & Neck Surgery. 131: 147-52. PMID 15723947 DOI: 10.1001/Archotol.131.2.147  0.43
2004 Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene. 23: 4793-806. PMID 15122337 DOI: 10.1038/Sj.Onc.1207632  0.602
2004 Chan AT, Tao Q, Robertson KD, Flinn IW, Mann RB, Klencke B, Kwan WH, Leung TW, Johnson PJ, Ambinder RF. Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1373-81. PMID 15007085 DOI: 10.1200/Jco.2004.04.185  0.425
2004 Murray PG, Qiu GH, Fu L, Waites ER, Srivastava G, Heys D, Agathanggelou A, Latif F, Grundy RG, Mann JR, Starczynski J, Crocker J, Parkes SE, Ambinder RF, Young LS, ... Tao Q, et al. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma. Oncogene. 23: 1326-31. PMID 14961078 DOI: 10.1038/Sj.Onc.1207313  0.553
2004 Ying J, Srivastava G, Gao Z, Zhang X, Murray P, Ambinder R, Tao Q. Promoter hypermethylation of the cyclin-dependent kinase inhibitor (CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and carcinomas. Blood. 103: 743-6. PMID 14702288 DOI: 10.1182/Blood-2003-09-3193  0.641
2003 Tao Q, Robertson KD. Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clinical Immunology (Orlando, Fla.). 109: 53-63. PMID 14585276 DOI: 10.1016/S1521-6616(03)00198-0  0.45
2002 Tao Q, Huang H, Geiman TM, Lim CY, Fu L, Qiu GH, Robertson KD. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Human Molecular Genetics. 11: 2091-102. PMID 12189161 DOI: 10.1093/Hmg/11.18.2091  0.409
2002 Tao Q, Yang J, Huang H, Swinnen LJ, Ambinder RF. Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: Implications for immune therapy American Journal of Pathology. 160: 1839-1845. PMID 12000735 DOI: 10.1016/S0002-9440(10)61130-3  0.3
2000 Yang J, Tao Q, Flinn IW, Murray PG, Post LE, Ma H, Piantadosi S, Caligiuri MA, Ambinder RF. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: Disappearance after rituximab therapy does not predict clinical response Blood. 96: 4055-4063. PMID 11110673 DOI: 10.1182/Blood.V96.13.4055.H8004055_4055_4063  0.303
1999 Ambinder RF, Robertson KD, Tao Q. DNA methylation and the Epstein-Barr virus Seminars in Cancer Biology. 9: 369-375. PMID 10547345 DOI: 10.1006/Scbi.1999.0137  0.45
1998 Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive Journal of Virology. 72: 7075-7083. PMID 9696800 DOI: 10.1128/Jvi.72.9.7075-7083.1998  0.529
1998 Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue Blood. 91: 1373-1381. PMID 9454768 DOI: 10.1182/Blood.V91.4.1373  0.515
1996 Chiang AK, Tao Q, Srivastava G, Ho FC. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. International Journal of Cancer. 68: 285-90. PMID 8903467 DOI: 10.1002/(Sici)1097-0215(19961104)68:3<285::Aid-Ijc3>3.0.Co;2-Y  0.395
1995 Tao Q, Srivastava G, Chan AC, Chung LP, Loke SL, Ho FC. Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. Journal of Medical Virology. 45: 71-7. PMID 7714494 DOI: 10.1002/Jmv.1890450114  0.325
Show low-probability matches.